Effect of estrogen on calcium-handling proteins, β-adrenergic receptors, and function in rat heart

Life Sciences

Volumn 79, Issue 13, 2006, Pages 1257-1267

  Chu, Sang Hui ^a   Goldspink, Paul ^b   Kowalski, Jill ^b   Beck, Jenny ^b   Schwertz, Dorie W ^b  

^a Yonsei University   (South Korea)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Contraction; Estrogen; Gender; Heart; Ovariectomy; Phospholamban; SERCA; Sex difference

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; CALCIUM HANDLING PROTEIN; ESTRADIOL BENZOATE; ESTROGEN; PHOSPHOLAMBAN; PROGESTERONE; PROTEIN; RYANODINE RECEPTOR; SESAME SEED OIL; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTROGEN THERAPY; FEMALE; HEART; IMMUNOBLOTTING; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; STATISTICAL SIGNIFICANCE; UTERUS WEIGHT; WEIGHT GAIN;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM-BINDING PROTEINS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEART; HEART VENTRICLES; HOMEOSTASIS; MEMBRANE PROTEINS; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; ORGAN SIZE; OVARIECTOMY; PAPILLARY MUSCLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SODIUM-CALCIUM EXCHANGER;

SESAMUM INDICUM;

EID: 33746912380     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.03.037     Document Type: Article

References (53)

1. Adams Jr. K.F., Sueta C.A., Gheorghiade M., O'Connor C.M., Schwartz T.A., Koch G.G., Uretsky B., Swedberg K., McKenna W., Soler-Soler J., and Califf R.M. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99 14 (1999) 1816-1821
2. Airey J.A., Beck C.F., Murakami K., Tanksley S.J., Deerinck T.J., Ellisman M.H., and Sutko J.L. Identification and localization of two triad junctional foot protein isoforms in mature avian fast twitch skeletal muscle. Journal of Biological Chemistry 265 24 (1990) 14187-14194
3. Alden K.J., Goldspink P.H., Buttrick P.M., and Garcia J. Protein kinase C-b2 augments calcium currents in mouse ventricular myocytes. American Journal of Physiology-Cellular Physiology 282 4 (2002) C768-C774
4. Alecrin I., Aldrighi J., Caldas M., Gebara O., Lopes N., and Ramires J. Acute and chromic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. Heart 90 7 (2004) 777-781
5. Beato M., Chavez S., and Truss M. Transcriptional regulation by steroid hormones. Steroids 61 4 (1996) 240-251
6. Beer S., Reincke M., Kral M., Lie S.Z., Steinhauer S., Schmidt H., Allolio B., and Neubauer S. Susceptibility to cardiac ischemia/reperfusion injury is modulated by chronic estrogen status. Journal of Cardiovascular Pharmacology 40 3 (2002) 420-428
7. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 6868 (2002) 198-205
8. Booth E.A., Marchesi M., Kilbourne E.J., and Lucchesi B.R. 17Beta-estradiol as a receptor-mediated cardioprotective agent. Journal of Pharmacology and Experimental Therapeutics 307 1 (2003) 395-401
9. Bowling N., Bloomquist W.E., Cohen M.L., Bryant H.U., Cole H.W., Magee D.E., Rowley E.R., and Vlahos C.J. Effects of prolonged ethinyl estradiol treatment on calcium channel binding and in vivo calcium-mediated hemodynamic responses in ovariectomized rats. Journal of Pharmacology and Experimental Therapeutics 281 1 (1997) 218-225
10. Bristow M.R., Minobe W., Rasmussen R., Larrabee P., Skerl L., Klein J., Anderson W., Murray F.L., Mestroni J., Karwande L., et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. Journal of Clinical Investigation 89 3 (1992) 803-815
11. Brower G.L., Gardner J.D., and Janicki J.S. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Molecular and Cellular Biochemistry 251 1-2 (2003) 89-95
12. Cavasin M.A., Sankey S.S., Yu A.L., Menon S., and Yang X.P. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology 284 5 (2003) H1560-H1569
13. Chu S.H., Sutherland K., Beck J., Kowalski J., Goldspink P., and Schwertz D. Sex differences in expression of calcium-handling proteins and beta-adrenergic receptors in rat heart ventricle. Life Sciences 76 23 (2005) 2735-2749
14. Coughlin S.S., and Tefft M.C. The epidemiology of idiopathic dilated cardiomyopathy in women: the Washington DC Dilated Cardiomyopathy Study. Epidemiology 5 4 (1994) 449-455
15. Curl C.L., Wendt I.R., Canny B.J., and Kotsanas G. Effects of ovariectomy and 17 beta-oestradiol replacement on [Ca2+]i in female rat cardiac myocytes. Clinical and Experimental Pharmacology and Physiology 30 7 (2003) 489-494
16. Fajer A.B., Holzbauer M., and Newport H.M. The contribution of the adrenal gland to the total amount of progesterone produced in the female rat. Journal of Physiology 214 1 (1971) 115-126
17. Fenkci V., Yilmazer M., Alpaslan M., Onrat E., and Fenkci S. The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study. Gynecologic and Obstetric Investigation 55 3 (2003) 139-144
18. Gardner J.D., Brower G.L., and Janicki J.S. Gender differences in cardiac remodeling secondary to chronic volume overload. Journal of Cardiac Failure 8 2 (2002) 101-107
19. Ghali J.K., Krause-Steinrauf H.J., Adams K.F., Khan S.S., Rosenberg Y.D., Yancy C.W., Young J.B., Goldman S., Peberdy M.A., and Lindenfeld J. Gender differences in advanced heart failure: insights from the BEST study. Journal of the American College of Cardiology 42 12 (2003) 2128-2134
20. Grohe C., Kahlert S., Lobbert K., Stimpel M., Karas R.H., Vetter H., and Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Letters 416 1 (1997) 107-112
21. Grohe C., Kahlert S., Lobbert K., and Vetter H. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. Journal of Endocrinology 156 2 (1998) R1-R7
22. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., and Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88 1 (1993) 107-115
23. Johnson B.D., Zheng W., Korach K.S., Scheuer T., Catterall W.A., and Rubanyi G.M. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. Journal of General Physiology 110 2 (1997) 135-140
24. Kadokami T., McTiernan C.F., Kubota T., Frye C.S., and Feldman A.M. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. Journal of Clinical Investigation 106 4 (2000) 589-597
25. Kam K.W., Qi J.S., Chen M., and Wong T.M. Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. Journal of Pharmacology and Experimental Therapeutics 309 1 (2004) 8-15
26. Kam K.W., Kravtsov G.M., Liu J., and Wong T.M. Increased PKA activity and its influence on isoprenaline-stimulated L-type Ca2+ channels in the heart from ovariectomized rats. British Journal of Pharmacology 144 7 (2005) 972-981
27. Katz A.M., and Reuter H. Cellular calcium and cardiac cell death. American Journal of Cardiology 44 1 (1979) 188-190
28. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., and Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. Journal of the American College of Cardiology 26 5 (1995) 1257-1263
29. Kolodgie F.D., Farb A., Litovsky S.H., Narula J., Jeffers L.A., Lee S.J., and Virmani R. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. Journal of Molecular and Cellular Cardiology 29 9 (1997) 2403-2414
30. Moss R.L., Gu Q., and Wong M. Estrogen: nontranscriptional signaling pathway. Recent Progress in Hormone Research 52 (1997) 33-68 (discussion 68-69)
31. Nitahara J.A., Cheng W., Liu Y., Li B., Leri A., Li P., Mogul D., Gambert S.R., Kajstura J., and Anversa P. Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. Journal of Molecular and Cellular Cardiology 30 3 (1998) 519-535
32. Patterson E., Ma L., Szabo B., Robinson C.P., and Thadani U. Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. Journal of Pharmacology and Experimental Therapeutics 284 2 (1998) 586-591
33. Reeve J.L., Duffy A.M., O'Brien T., and Samali A. Don't lose heart-therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. Journal of Cellular and Molecular Medicine 9 (2005) 609-622
34. Reis S.E., Holubkov R., Young J.B., White B.G., Cohn J.N., and Feldman A.M. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. Journal of the American College of Cardiology 36 2 (2000) 529-533
35. Ren J., Hintz K.K., Roughead Z.K., Duan J., Colligan P.B., Ren B.H., Lee K.J., and Zeng H. Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. American Journal of Physiology. Heart and Circulatory Physiology 284 5 (2003) H1800-H1807
36. Rosenkranz-Weiss P., Tomek R.J., Mathew J., and Eghbali M. Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. Journal of Molecular and Cellular Cardiology 26 2 (1994) 261-270
37. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medicine Association 288 3 (2002) 321-333
38. Sbarouni E., Iliodromitis E., Bofilis E., Kyriakides Z., and Kremastinos D. Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size. European Journal of Pharmacology 467 1-3 (2003) 163-168
39. Schaible T.F., Malhotra A., Ciambrone G., and Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circulation Research 54 1 (1984) 38-49
40. Scheuer J., Malhotra A., Schaible T.F., and Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circulation Research 61 1 (1987) 12-19
41. Schouten V.J., van Deen J.K., de Tombe P., and Verveen A.A. Force-interval relationship in heart muscle of mammals. A calcium compartment model. Biophysical Journal 51 1 (1987) 13-26
42. Schwertz D.W., Beck J.M., Kowalski J.M., and Ross J.D. Sex differences in the response of rat heart ventricle to calcium. Biological Research in Nursing 5 4 (2004) 286-298
43. Sites C.K., Tischler M.D., Blackman J.A., Niggel J., Fairbank J.T., O'Connell M., and Ashikaga T. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertility and Sterility 71 1 (1999) 137-143
44. Tamura T., Said S., and Gerdes A.M. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension 33 2 (1999) 676-680
45. Thawornkaiwong A., Preawnim S., and Wattanapermpool J. Upregulation of beta 1-adrenergic receptors in ovariectomized rat hearts. Life Sciences 72 16 (2003) 1813-1824
46. Toscano V., Balducci R., Bianchi P., Guglielmi R., Mangiantini A., and Sciarra F. Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. Journal of Steroid Biochemistry and Molecular Biology 43 5 (1992) 431-437
47. Vizgirda V.M., Wahler G.M., Sondgeroth K.L., Ziolo M.T., and Schwertz D.W. Mechanisms of sex differences in rat cardiac myocyte response to beta-adrenergic stimulation. American Journal of Physiology. Heart and Circulatory Physiology 282 1 (2002) H256-H263
48. Wattanapermpool J. Increase in calcium responsiveness of cardiac myofilament activation in ovariectomized rats. Life Sciences 63 11 (1998) 955-964
49. Wattanapermpool J., Riabroy T., and Preawnim S. Estrogen supplement prevents the calcium hypersensitivity of cardiac myofilaments in ovariectomized rats. Life Sciences 66 6 (2000) 533-543
50. Wu J.C., Nasseri B.A., Bloch K.D., Picard M.H., and Scherrer-Crosbie M. Influence of sex on ventricular remodeling after myocardial infarction in mice. Journal of the American Society of Echocardiography 16 11 (2003) 1158-1162
51. Yano M., Ikeda Y., and Matsuzaki M. Altered intracellular Ca2+ handling in heart failure. Journal of Clinical Investigation 115 3 (2005) 556-564
52. Yildirir A., Yarali H., Kabakci G., Aybar F., Akgul E., and Bukulmez O. Hormone replacement therapy to improve left ventricular diastolic functions in healthy postmenopausal women. International Journal of Gynaecology and Obstetrics 75 3 (2001) 273-278
53. Zhai P., Eurell T.E., Cotthaus R., Jeffery E.H., Bahr J.M., and Gross D.R. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. American Journal of Physiology. Heart and Circulatory Physiology 279 6 (2000) H2766-H2775